Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT02228538
Other study ID # 13-003
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date October 2013
Est. completion date September 2016

Study information

Verified date October 2023
Source Restor3D
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to obtain patient oriented and clinically oriented physical function outcomes both pre-operatively and post-operatively in patients receiving a total knee arthroplasty.


Description:

This study aims to use up to 75 patients at 3 centers to determine a baseline short-term post-operative physical function status of patients undergoing a total knee arthroplasty through patient and clinically based assessments. The KOOS score will collect data on the patient's physical function, stiffness and pain. The BERG balance, TUG, and TUDS tests will be used quantitatively to assess the patient's ability to conduct activities of daily living like walking for an extended period of time, standing from a seated position, and maintaining balance while performing a series of actions.


Recruitment information / eligibility

Status Terminated
Enrollment 7
Est. completion date September 2016
Est. primary completion date May 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient is male or non-pregnant female age 18 years or older at time of study - Patient is a candidate for a total knee arthroplasty - Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation Exclusion Criteria: - Patients with a primary diagnosis other than osteoarthritis of the knee as determined by an orthopedic surgeon - Patients who have had any previous lower extremity procedure - Patients with a BMI greater than or equal to 40 - Patients with an active infection within the affected knee joint - Patients with a neuromuscular or neurosensory deficiency that may limit the ability of the patient to evaluate the safety and efficacy of the device - Patients diagnosed with systemic disease or metabolic disorder leading to progressive bone deterioration (e.g. Lupus Erythematosus, Paget's disease) - Patients immunologically suppressed or receiving chronic steroids in excess of normal physiological requirements (e.g. greater than 30 days) - Patients with a known sensitivity to device materials - Non-English speaking patients - Patient is a prisoner

Study Design


Intervention

Device:
Total knee arthroplasty patients
ConforMIS iTotal (CR) knee implant system & off-the-shelf standard knee implant system from various manufacturers

Locations

Country Name City State
United States Ochsner Clinic Foundation New Orleans Louisiana

Sponsors (2)

Lead Sponsor Collaborator
Restor3D Ochsner Health System

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Timed Functional Tests at 6 weeks Assess patient functional outcomes over time. Comparing times from pre-op to post op of patients performing the same functional tests. 6 weeks post-op
Primary Timed Functional testing at 6 months Assess patient functional outcomes over time. Comparing times from pre-op to post op of patients performing the same functional tests. 6 months post op
Primary Timed Functional Testing at 1 year Assess patient functional outcomes over time. Comparing times from pre-op to post op of patients performing the same functional tests. 1 year post-op
Secondary Outcome questionnaires at 6 weeks Assess knee pain and function scores over time. Comparing questionnaire scores from pre-op to post op of patients. 6 weeks post-op
Secondary Outcome questionnaires at 6 months Assess knee pain and function scores over time. Comparing questionnaire scores from pre-op to post op of patients. 6 months post-op
Secondary Outcome questionnaires at 1 year Assess knee pain and function scores over time. Comparing questionnaire scores from pre-op to post op of patients. 1 year post op
See also
  Status Clinical Trial Phase
Completed NCT03277066 - A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis Phase 2
Recruiting NCT03090698 - Outcomes of Injections in Patients Waiting for Total Knee Replacement Phase 4
Completed NCT02556710 - A Study to Evaluate the Efficacy & Safety of an Intra-Articular Ampion Injection for Pain of Osteoarthritis of the Knee Phase 3
Withdrawn NCT02237846 - Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis Phase 1/Phase 2
Completed NCT02242435 - A Multiple Injection Study Evaluating Safety and Efficacy of Ampion in Osteoarthritis Phase 3
Completed NCT01849445 - Targeted Rehabilitation to Improve Outcome After Knee Replacement- A Physiotherapy Study N/A
Completed NCT02096393 - Patient Specific Instrumentation in TKR N/A
Completed NCT01704157 - A Prospective Study Evaluating the Treatment of Knee Osteoarthritis With the Cryo-Touch III Device N/A
Active, not recruiting NCT01374230 - Long-Term Multicenter Evaluation of the E1® Tibial Bearing N/A
Completed NCT02156440 - Cross-over Study of the Efficacy and Safety of SierraSil Joint Formula 14 in Osteoarthritis of the Knee Phase 2
Completed NCT01410409 - Structured Treatment of Osteoarthritis of the Knee With or Without Total Knee Replacement N/A
Not yet recruiting NCT01270412 - Platelet Rich Plasma (PRP) as a Treatment for Knee Osteoarthritis PRP as a Treatment for Knee Osteoarthritis Phase 2/Phase 3
Completed NCT01207115 - A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee Phase 2
Completed NCT00988091 - Investigation of 1.2% Sodium Hyaluronate for Treatment of Painful Chronic Osteoarthritis of the Knee Phase 3
Completed NCT00970008 - Exploring Massage Benefits for Arthritis of the Knee Phase 2
Completed NCT01331278 - A Comparative Study of Knee Systems Phase 4
Completed NCT00531427 - Buprenorphine Transdermal System (BTDS) in Subjects w/Mod-sev Osteoarthritis (OA) Chronic Pain of Knee Phase 3
Completed NCT00792727 - HKT-500 in Adult Patients With Osteoarthritis (OA) Knee Pain Phase 3
Completed NCT00449696 - Gel-200 Versus Placebo in Osteoarthritis of the Knee Phase 3
Completed NCT04145011 - Coolief Cooled Radiofrequency vs. Conventional Radiofrequency to Manage OA Knee Pain N/A